In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Member Benefit

This content is only available year-round to ESC Professional Members, Fellows of the ESC, and Young Combined Members

Cardiopulmonary performance testing using a robotics-assisted tilt table: feasibility assessment in able bodied subjects.

Session Poster Session 4

Speaker Jittima Saengsuwan

Event : ESC Congress 2013

  • Topic : preventive cardiology
  • Sub-topic : Exercise Testing
  • Session type : Poster Session

Authors : J Saengsuwan (Bern,CH), M Laubacher (Burgdorf,CH), T Nef (Bern,CH), K Hunt (Burgdorf,CH)

Authors:
J. Saengsuwan1 , M. Laubacher2 , T. Nef3 , K. Hunt2 , 1Bern University of Applied Sciences and Bern University - Bern - Switzerland , 2Institute for Rehabilitation and Performance Technology, Bern University of Applied Sciences - Burgdorf - Switzerland , 3ARTORG Center for Biomedical Engineering Research, Gerontechnology and Rehabilitation - Bern - Switzerland ,

Topic(s):
Exercise testing and training

Citation:
European Heart Journal ( 2013 ) 34 ( Abstract Supplement ), 634

Purpose: Robotics-assisted tilt table technology with integrated leg drives for basic stepping functionality is clinically available for patients with neurological impairments. Initially introduced for early rehabilitation, it provides cyclical stepping movement and physiological loading in immobilized patients. This technology provides stability and support in patients with neurological disorders for whom weakness, balance and coordination problems would preclude cardiopulmonary performance testing using a treadmill or cycle ergometer. This type of device may facilitate the estimation of peak oxygen uptake and other important cardiopulmonary performance parameters in patients who have neurological deficits. The aim of the present study was to assess the feasibility and safety of this device for peak cardiopulmonary performance testing in able-bodied subjects.

Methods: A robotics-assisted tilt table (Erigo, Hocoma AG, Switzerland) was augmented with force sensors in the thigh cuffs and a work rate estimation algorithm. A custom visual feedback system was employed to guide the subjects' work rate and to provide real time feedback of actual work rate. Each subject carried out an incremental exercise test to the limit of functional capacity with a work rate increment of 5 W/minute in female subjects and 8 W/minute in males. Outcome measures were peak oxygen uptake (VO2peak), peak heart rate (HRpeak), respiratory exchange ratio (RER), peak work rate (WRpeak) and the Borg CR10 scale to measure exertion and leg fatigue.

Results: 11 able-bodied subjects were included (9 male, 2 female; age 29.6±7.1 years: mean ± SD). Resting VO2 was 4.6±0.7 ml/kg/min and VO2peak was 32.4±5.1 ml/kg/min. All participants reached at least 85% of their predicted HRmax value. RER at peak VO2 was 1.02±0.07. Eight participants (72.7%) reached their peak VO2 in 8-12 minutes, which is considered the optimal duration. The average WRpeak was 65.7 W for males and 41.5 W for females. All participants reported a Borg CR10 value for exertion and leg fatigue of 7 or more. There were no serious adverse events.

Conclusions: The robotics-assisted tilt table augmented with work rate estimation and a visual feedback system is a feasible and safe method for peak cardiopulmonary performance testing in able-bodied subjects. Future work will evaluate test-retest reliability and compare peak cardiorespiratory performance values with those obtained from a treadmill and a cycle ergometer. The approach will then be piloted in subjects with neurological impairments.

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are